Biotech stocks could rally 19%: Technician

Biotech stocks surged on Wednesday, with the popular biotech ETF (IBB) rising almost 5 percent. And according to one technician, there are more gains ahead for the recently beleaguered biotech stocks.

On Wednesday, Rich Ross of Evercore ISI said the biotech ETF could spike almost 19 percent. A previous bounce off the $285 support level indicates the potential for another rally, he said.

"I think this double bottom in here is going to set this stage for a move as high as the 100-day moving average," he said Wednesday on CNBC's "Trading Nation." "It was the break below that 100-day that really set the stock off to the downside."

If IBB reaches the 100-day moving average line at $360, that would be about a 19 percent move from its Wednesday closing price of $303.

Wednesday's bounce follows a steep sell-off for the industry ETF, which has fallen 14 percent in one month. IBB has struggled under a broader stock sell-off, as well as accusations of price gouging in some biotech companies that could lead to greater regulation for the industry.

Read MoreHere's the big problem with biotech: Trader

"In the recent market decline, no sector has been hit quite as hard as the biotechs," Ross said. "In addition to that broad market weakness, we had a tweet from Hillary Clinton on cracking down on price gouging if she were to be elected president. That's put pressure on the group here."

With its recent losses, the S&P 500 biotech industry has given up prodigious gains from the past year. The group of stocks are now down about 1.5 percent in one year.

Want to be a part of the Trading Nation? If you'd like to call in to our live Wednesday show, email your name, number and a question to


Trades to Watch

Trader Bios


Trading Nation is a multimedia financial news program that shows investors and traders how to use the news of the day to their advantage. This is where experts from across the financial world – including macro strategists, technical analysts, stock-pickers, and traders who specialize in options, currencies, and fixed income – come together to find the best ways to capitalize on recent developments in the market. Trading Nation: Where headlines become opportunities.

Michael Santoli

Michael Santoli joined CNBC in October 2015 as a Senior Markets Commentator, based at the network's Global Headquarters in Englewood Cliffs, N.J.  Santoli brings his extensive markets expertise to CNBC's Business Day programming, with a regular appearance on CNBC's “Closing Bell (M-F, 3PM-5PM ET).   In addition, he contributes to CNBCand CNBC PRO, writing regular articles and creating original digital videos.

Previously, Santoli was a Senior Columnist at Yahoo Finance, where he wrote analysis and commentary on the stock market, corporate news and the economy. He also appeared on Yahoo Finance video programs, where he offered insights on the most important business stories of the day, and was a regular contributor to CNBC and other networks.

Follow Michael Santoli on Twitter @michaelsantoli

Read more